Historical Valuation
Genenta Science SPA (GNTA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -8.73. The fair price of Genenta Science SPA (GNTA) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：1.41
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Genenta Science SPA (GNTA) has a current Price-to-Book (P/B) ratio of 1.90. Compared to its 3-year average P/B ratio of 3.89 , the current P/B ratio is approximately -51.17% higher. Relative to its 5-year average P/B ratio of 3.70, the current P/B ratio is about -48.53% higher. Genenta Science SPA (GNTA) has a Forward Free Cash Flow (FCF) yield of approximately -34.42%. Compared to its 3-year average FCF yield of -13.39%, the current FCF yield is approximately 157.04% lower. Relative to its 5-year average FCF yield of -11.31% , the current FCF yield is about 204.44% lower.
P/B
Median3y
3.89
Median5y
3.70
FCF Yield
Median3y
-13.39
Median5y
-11.31
Competitors Valuation Multiple
AI Analysis for GNTA
The average P/S ratio for GNTA competitors is 1.52, providing a benchmark for relative valuation. Genenta Science SPA Corp (GNTA.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for GNTA
1Y
3Y
5Y
Market capitalization of GNTA increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of GNTA in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is GNTA currently overvalued or undervalued?
Genenta Science SPA (GNTA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -8.73. The fair price of Genenta Science SPA (GNTA) is between NaN to NaN according to relative valuation methord.
What is Genenta Science SPA (GNTA) fair value?
GNTA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Genenta Science SPA (GNTA) is between NaN to NaN according to relative valuation methord.
How does GNTA's valuation metrics compare to the industry average?
The average P/S ratio for GNTA's competitors is 1.52, providing a benchmark for relative valuation. Genenta Science SPA Corp (GNTA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Genenta Science SPA (GNTA) as of Jan 10 2026?
As of Jan 10 2026, Genenta Science SPA (GNTA) has a P/B ratio of 1.90. This indicates that the market values GNTA at 1.90 times its book value.
What is the current FCF Yield for Genenta Science SPA (GNTA) as of Jan 10 2026?
As of Jan 10 2026, Genenta Science SPA (GNTA) has a FCF Yield of -34.42%. This means that for every dollar of Genenta Science SPA’s market capitalization, the company generates -34.42 cents in free cash flow.
What is the current Forward P/E ratio for Genenta Science SPA (GNTA) as of Jan 10 2026?
As of Jan 10 2026, Genenta Science SPA (GNTA) has a Forward P/E ratio of -2.46. This means the market is willing to pay $-2.46 for every dollar of Genenta Science SPA’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Genenta Science SPA (GNTA) as of Jan 10 2026?
As of Jan 10 2026, Genenta Science SPA (GNTA) has a Forward P/S ratio of 0.00. This means the market is valuing GNTA at $0.00 for every dollar of expected revenue over the next 12 months.